Held, G. and Poeschel, V and Altmann, B. and Illmer, T. and Andre, M. and Dreyling, M. and Maisonneuve, H. and Tilly, H. and Mayer, S. and Casasnovas, R. -O and Le Gouill, S. and Offner, F. C. and Cartron, G. and Kerkhoff, A. and Weber, T. and Hoffmann, J. and Ziepert, M. and Klapper, W. and Itti, E. and Hellwig, D. and Natchkebia, G. and De Leval, L. and Rosenwald, A. and Haioun, C. and Dercle, L. and Gaulard, P. and Houot, R. (2021) Nivolumab in combination with Gemcitabine and Oxaliplatin (GemOx) in Relapse/Refractory T-cell Lymphoma: Preliminary results of the experimental arm of the NIVEAU trial. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.
Full text not available from this repository.| Item Type: | Conference or Workshop Item (Speech) |
|---|---|
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) Medicine > Abteilung für Nuklearmedizin |
| Depositing User: | Petra Gürster |
| Date Deposited: | 01 Dec 2022 10:10 |
| Last Modified: | 01 Dec 2022 10:10 |
| URI: | https://pred.uni-regensburg.de/id/eprint/47793 |
Actions (login required)
 |
View Item |
